Pneumotox Online
v2.2
  • RSS Feed
  • Contact
  • News
  • Diagnosing DIRD
  • Browse
  • Available on AppStore Available on AppStore

The Drug-Induced Respiratory Disease Website

Philippe Camus, M.D.

Dijon, France

  • Home
  • Browse by »
  • Drugs
  • Patterns

Pazopanib

2

XII.a Left or biventricular dysfunction/failure

1
Last update : 21/08/2018
 
Search
Advanced search
Identify causative drugs
Diagnosing DIRD
1
Drug and radiation history
2
Drug singularity - Correct identification of the drug
3
Consistent timing of exposure v. onset of symptoms
4
Clinical, imaging, BAL, pathological pattern consistent with the specific drug
5
Careful exlusion of another cause
6
Remission of symptoms with removal of drug
7
Recurrence with rechallenge (rarely advisable)
8
Causality assessment
More detailed checklist

Publications

Pazopanib-induced fatal heart failure in a patient with unresectable soft tissue sarcoma and review of literature.
Journal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners 2020 Apr;26;768-774 2020 Apr
Cardiotoxicity Monitoring in Patients Treated with Tyrosine Kinase Inhibitors.
The oncologist 2019 Jul;24;e600-e602 2019 Jul
Rapid and life-threatening heart failure induced by pazopanib.
BMJ case reports 2018 Aug 16;2018; 2018 Aug 16

Powered by

  • ^
  • Contact
  • Cookies
  • About

The Pneumotox website uses cookies. By accessing or using our website, you consent to the collection, use and disclosure of the garnered information in accordance with our privacy policy.

Learn more about cookies